LUMOS PHARMA INC. - C
3,8501
08-октября-24 15:57:28
15 мин. задержка
Акции
-0,0099
-0,26%
Сегодняшний диапазон
3,6500 - 3,9400
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
12 дек 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Host KOL Webinar to Discuss Interim Phase 2 Data from OraGrowtH Trials in PGHD
29 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference
22 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
14 ноя 2022 06:10:00 Источник Nasdaq GlobeNewswire
-
14 ноя 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
26 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
31 авг 2022 09:00:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma Announces Share Repurchase Program
16 авг 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
09 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
27 июл 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in Upcoming Investor Conferences
16 май 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
10 май 2022 16:01:01 Источник Nasdaq GlobeNewswire
-
05 май 2022 09:00:01 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
26 апр 2022 09:00:03 Источник Nasdaq GlobeNewswire
-
11 апр 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in the Cantor Rare Disease Symposium
23 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
10 мар 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Participate in Upcoming Investor Conferences
10 мар 2022 09:00:01 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Report Full Year 2021 Financial Results and Host Conference Call on March 10, 2022
23 фев 2022 09:00:01 Источник Nasdaq GlobeNewswire
-
Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
05 янв 2022 09:00:01 Источник Nasdaq GlobeNewswire